She has extensive experience in translational research focused on personalised medicine, biomarker discovery and lymph node immunobiology. Her research aims to unravel the biological processes leading to autoimmune diseases with an ultimate goal of discovering stage-specific drug targets and the development of tailor-made immunotherapies aimed at halting disease progression even before onset of disease.